How the European Commission's €5 billion scaleup fund made its first healthcare bet — and what it says about Europe's plan to stop losing its best companies.
Who this is for: pharma partnerships teams, biotech investors, and operators tracking which AI-native drug discovery platforms are actually moving molecules into clinical trials, not just publishing benchmarks.
Tempus AI, Abridge, Microsoft Dragon Copilot, Aidoc, PathAI, Viz.ai, and Butterfly Network, ranked by clinical adoption, FDA clearances, and funding as of August 2026.
Four out of five hospital AI pilots never reach production. Edgewisely's take on why the culprit is data and governance, not model quality — and what the systems getting real ROI are doing differently.
Get Edgewisely in your inbox
Business stories that matter, free. Enter your email — no password, no account to set up.